Your Child's Doctor Can Now Order a Genetic Test That Changes Everything

The Food and Drug Administration (FDA) has granted breakthrough device designation to comprehensive genetic tests that any pediatrician can now order directly, potentially revolutionizing how doctors diagnose mysterious childhood conditions. This marks a major shift from the traditional approach where only genetics specialists could order such advanced testing.

What Makes These New Genetic Tests Different?

The breakthrough designation applies to GeneDx's whole-genome and whole-exome sequencing tests, which can analyze either 2% of a child's genetic code (exome) or the complete genetic blueprint (genome). "I think, classically, certainly when I was trained in medicine, we referred patients to go see a genetics specialist," said Mimi Lee, MD, PhD. "But now we're realizing that this is a tool that can be ubiquitously and universally used by physicians and physician teams...just like ordering a laboratory test or ordering a radiographic image."

Exome sequencing focuses on protein-coding regions where many disease-causing genetic variants are found, while whole-genome sequencing captures structural and non-coding regions that may also contribute to illness. This comprehensive approach allows doctors to identify objective genetic drivers of disease, particularly in children with unexplained or rare conditions.

How Will This Change Your Child's Care?

The new testing capability means pediatricians can move beyond symptom-based diagnoses toward individualized treatment strategies. Instead of treating every child with the same diagnosis identically, doctors will be able to tailor care based on each child's unique genetic makeup.

The benefits of this approach include:

• Faster Diagnosis: General pediatricians can order genetic testing immediately when standard evaluations fail to provide answers, eliminating referral delays
• Precision Treatment: As doctors learn more about the remaining 98% of the genome beyond protein-coding regions, they can target conditions much more precisely
• Enhanced Pediatric Care: The technology strengthens rather than replaces the role of general pediatricians by giving them powerful diagnostic tools

"We will no longer have to treat every child like they are exactly the same as the next one with the same diagnosis," Lee explained. "This is going to help elevate the role of the general pediatrician...as just another tool to really home in on what's going on with this particular child vs the next one."

Why Did the FDA Fast-Track This Technology?

The FDA's breakthrough device designation is reserved for technologies that may offer more effective diagnosis of serious or life-threatening conditions. GeneDx deliberately pursued FDA review to establish their tests as approved medical diagnostics rather than research tools. "The fact that we decided to go ahead and bring it to the FDA to have it approved as a medical test was a big thing," Lee noted. "And the fact that they responded by assigning it breakthrough device designation was really exciting for us and, I think, exciting for patients in the field."

This regulatory recognition signals that genomic testing can meaningfully improve diagnostic precision in pediatric care. As the technology becomes more widely adopted, Lee expects rapid advances in understanding human biology that will support the development of novel therapies or help repurpose existing treatments for specific genetic variants.

The designation represents a fundamental shift in how genetic testing integrates into everyday clinical practice, making sophisticated diagnostic tools accessible to frontline pediatricians who see children with puzzling symptoms every day.